Acadia shareholders elect three Class III directors, approve say-on-pay, ratify EY auditor

ACADIA PHARMACEUTICALS INC

Elected Catherine Owen Adams, Laura A. Brege, and Elizabeth A. Garofalo, M.D. as Class III directors; each received >129M votes for.
Advisory vote on named executive officer compensation approved: 142.2M for, 2.8M against, 108.8K abstain.
Ernst & Young LLP ratified as independent auditor for FY2025: 154.5M for, 926.5K against, 35.0K abstain.
Broker non-votes of 10.3M shares on director election and advisory compensation vote.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.